THE EPIDEMIOLOGY OF MUMPS IN SOUTHERN ALBERTA, 1980-1982
The full spectrum of mumps in Southern Alberta was studied over the years 1980–1982.In the community, a random sample of 3,497 children was tested for prevalence of immunity to mumps. The 1,816 who were not Immune were retested after one year. The incidence of new immunity was 16.5%. Most seroconver...
Gespeichert in:
| Veröffentlicht in: | American journal of epidemiology 1989-10, Vol.130 (4), p.736-749 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 749 |
|---|---|
| container_issue | 4 |
| container_start_page | 736 |
| container_title | American journal of epidemiology |
| container_volume | 130 |
| creator | FALK, W.A. BUCHAN, K. DOW, M. GARSON, J.Z. HILL, E. NOSAL, M. TARRANT, M. WESTBURY, R C. WHITE, F.M.M. |
| description | The full spectrum of mumps in Southern Alberta was studied over the years 1980–1982.In the community, a random sample of 3,497 children was tested for prevalence of immunity to mumps. The 1,816 who were not Immune were retested after one year. The incidence of new immunity was 16.5%. Most seroconverters had no illness suggestive of mumps. History of previous mumps or immunization were found to be unreliable predictors of serotogic immune status. In the family study, information was obtained on 342 cases diagnosed as mumps by family physician recorders.The overall complication rate was 10.8% and the secondary attack rate within families was 11.7% Hospital records of all 25 patients admitted in Calgary with mumps during the same period were analyzed. Estimated costs of unopposed mumps over 20 years compared with the estimated costs of vaccination showed that a vaccination program could give a benefit-cost ratio between 6.4 and 247 These studies show that mumps is a mild disease with relatively few serious complications or sequelae Even so, there would be definite medical and economic benefit with immunization. A low-cost addition of mumps vaccine to the immunization program would be justified. |
| doi_str_mv | 10.1093/oxfordjournals.aje.a115395 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79201394</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15460087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-89515e7a3f1d0fdd0ec8a9f7cd8dcee10c993a6deb522cefa716d0edae9fb5423</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS0EKqHwEZBWgDh1w4y9ttfc0nTDRkqa0ibiz8VyvLaUkGSLnUjl2-MqSyS4cJk5vN-8J80j5A1CH0GxD-2Db0Ozbg9hZzaxb9aubxA5U_wJ6WEhRS4oF09JDwBorqigz8mLGNcAiIrDGTmjHLhA2iPlvK6y6mZ8VU3Hs8ns07dsNsqmi-nNXTa-zu5mi6TfXmeDyWV1Ox9cZKhKyNOgL8kzn8Ldq26fk8Womg_rPJmMh4NJbosC9nmpOHInDfPYgG8acLY0ykvblI11DsEqxYxo3JJTap03EkWCGuOUX_KCsnPy_uh7H9qfBxf3eruK1m02ZufaQ9RSUUCmiv-CyAsBUMoEvv0H_PNJjQyE4EVBy0R9PFI2tDEG5_V9WG1N-KUR9GML-u8WdGpBdy2k49ddxGG5dc3ptHt70t91uonWbHwwO7uKJ0xIxqTEhOVHbBX37uEkm_DjEZFc11-_68svn2uo1VCP2G9EEJ8F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1306654428</pqid></control><display><type>article</type><title>THE EPIDEMIOLOGY OF MUMPS IN SOUTHERN ALBERTA, 1980-1982</title><source>MEDLINE</source><source>Periodicals Index Online</source><source>Oxford Journals Archive</source><creator>FALK, W.A. ; BUCHAN, K. ; DOW, M. ; GARSON, J.Z. ; HILL, E. ; NOSAL, M. ; TARRANT, M. ; WESTBURY, R C. ; WHITE, F.M.M.</creator><creatorcontrib>FALK, W.A. ; BUCHAN, K. ; DOW, M. ; GARSON, J.Z. ; HILL, E. ; NOSAL, M. ; TARRANT, M. ; WESTBURY, R C. ; WHITE, F.M.M.</creatorcontrib><description>The full spectrum of mumps in Southern Alberta was studied over the years 1980–1982.In the community, a random sample of 3,497 children was tested for prevalence of immunity to mumps. The 1,816 who were not Immune were retested after one year. The incidence of new immunity was 16.5%. Most seroconverters had no illness suggestive of mumps. History of previous mumps or immunization were found to be unreliable predictors of serotogic immune status. In the family study, information was obtained on 342 cases diagnosed as mumps by family physician recorders.The overall complication rate was 10.8% and the secondary attack rate within families was 11.7% Hospital records of all 25 patients admitted in Calgary with mumps during the same period were analyzed. Estimated costs of unopposed mumps over 20 years compared with the estimated costs of vaccination showed that a vaccination program could give a benefit-cost ratio between 6.4 and 247 These studies show that mumps is a mild disease with relatively few serious complications or sequelae Even so, there would be definite medical and economic benefit with immunization. A low-cost addition of mumps vaccine to the immunization program would be justified.</description><identifier>ISSN: 0002-9262</identifier><identifier>EISSN: 1476-6256</identifier><identifier>DOI: 10.1093/oxfordjournals.aje.a115395</identifier><identifier>PMID: 2505612</identifier><identifier>CODEN: AJEPAS</identifier><language>eng</language><publisher>Cary, NC: Oxford University Press</publisher><subject>Adolescent ; Alberta ; Antibodies, Viral - analysis ; Biological and medical sciences ; Child ; Child, Preschool ; Cost-Benefit Analysis ; Epidemiologic Methods ; Family Practice ; Human viral diseases ; Humans ; immunity ; Immunologic Techniques - economics ; Infant ; Infectious diseases ; Medical sciences ; morbidity ; mumps ; Mumps - epidemiology ; Mumps - immunology ; Mumps - prevention & control ; mumps vaccine ; Mumps Vaccine - therapeutic use ; mumps virus ; Outcome and Process Assessment (Health Care) ; outcome and process assessment (hearth care) ; vaccines ; Viral diseases ; Viral diseases of the respiratory system and ent viral diseases</subject><ispartof>American journal of epidemiology, 1989-10, Vol.130 (4), p.736-749</ispartof><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-89515e7a3f1d0fdd0ec8a9f7cd8dcee10c993a6deb522cefa716d0edae9fb5423</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27869,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6733771$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2505612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FALK, W.A.</creatorcontrib><creatorcontrib>BUCHAN, K.</creatorcontrib><creatorcontrib>DOW, M.</creatorcontrib><creatorcontrib>GARSON, J.Z.</creatorcontrib><creatorcontrib>HILL, E.</creatorcontrib><creatorcontrib>NOSAL, M.</creatorcontrib><creatorcontrib>TARRANT, M.</creatorcontrib><creatorcontrib>WESTBURY, R C.</creatorcontrib><creatorcontrib>WHITE, F.M.M.</creatorcontrib><title>THE EPIDEMIOLOGY OF MUMPS IN SOUTHERN ALBERTA, 1980-1982</title><title>American journal of epidemiology</title><addtitle>Am J Epidemiol</addtitle><description>The full spectrum of mumps in Southern Alberta was studied over the years 1980–1982.In the community, a random sample of 3,497 children was tested for prevalence of immunity to mumps. The 1,816 who were not Immune were retested after one year. The incidence of new immunity was 16.5%. Most seroconverters had no illness suggestive of mumps. History of previous mumps or immunization were found to be unreliable predictors of serotogic immune status. In the family study, information was obtained on 342 cases diagnosed as mumps by family physician recorders.The overall complication rate was 10.8% and the secondary attack rate within families was 11.7% Hospital records of all 25 patients admitted in Calgary with mumps during the same period were analyzed. Estimated costs of unopposed mumps over 20 years compared with the estimated costs of vaccination showed that a vaccination program could give a benefit-cost ratio between 6.4 and 247 These studies show that mumps is a mild disease with relatively few serious complications or sequelae Even so, there would be definite medical and economic benefit with immunization. A low-cost addition of mumps vaccine to the immunization program would be justified.</description><subject>Adolescent</subject><subject>Alberta</subject><subject>Antibodies, Viral - analysis</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cost-Benefit Analysis</subject><subject>Epidemiologic Methods</subject><subject>Family Practice</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>immunity</subject><subject>Immunologic Techniques - economics</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>morbidity</subject><subject>mumps</subject><subject>Mumps - epidemiology</subject><subject>Mumps - immunology</subject><subject>Mumps - prevention & control</subject><subject>mumps vaccine</subject><subject>Mumps Vaccine - therapeutic use</subject><subject>mumps virus</subject><subject>Outcome and Process Assessment (Health Care)</subject><subject>outcome and process assessment (hearth care)</subject><subject>vaccines</subject><subject>Viral diseases</subject><subject>Viral diseases of the respiratory system and ent viral diseases</subject><issn>0002-9262</issn><issn>1476-6256</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNqFkU9vEzEQxS0EKqHwEZBWgDh1w4y9ttfc0nTDRkqa0ibiz8VyvLaUkGSLnUjl2-MqSyS4cJk5vN-8J80j5A1CH0GxD-2Db0Ozbg9hZzaxb9aubxA5U_wJ6WEhRS4oF09JDwBorqigz8mLGNcAiIrDGTmjHLhA2iPlvK6y6mZ8VU3Hs8ns07dsNsqmi-nNXTa-zu5mi6TfXmeDyWV1Ox9cZKhKyNOgL8kzn8Ldq26fk8Womg_rPJmMh4NJbosC9nmpOHInDfPYgG8acLY0ykvblI11DsEqxYxo3JJTap03EkWCGuOUX_KCsnPy_uh7H9qfBxf3eruK1m02ZufaQ9RSUUCmiv-CyAsBUMoEvv0H_PNJjQyE4EVBy0R9PFI2tDEG5_V9WG1N-KUR9GML-u8WdGpBdy2k49ddxGG5dc3ptHt70t91uonWbHwwO7uKJ0xIxqTEhOVHbBX37uEkm_DjEZFc11-_68svn2uo1VCP2G9EEJ8F</recordid><startdate>19891001</startdate><enddate>19891001</enddate><creator>FALK, W.A.</creator><creator>BUCHAN, K.</creator><creator>DOW, M.</creator><creator>GARSON, J.Z.</creator><creator>HILL, E.</creator><creator>NOSAL, M.</creator><creator>TARRANT, M.</creator><creator>WESTBURY, R C.</creator><creator>WHITE, F.M.M.</creator><general>Oxford University Press</general><general>School of Hygiene and Public Health of the Johns Hopkins University</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HVZBN</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7T2</scope><scope>7T5</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19891001</creationdate><title>THE EPIDEMIOLOGY OF MUMPS IN SOUTHERN ALBERTA, 1980-1982</title><author>FALK, W.A. ; BUCHAN, K. ; DOW, M. ; GARSON, J.Z. ; HILL, E. ; NOSAL, M. ; TARRANT, M. ; WESTBURY, R C. ; WHITE, F.M.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-89515e7a3f1d0fdd0ec8a9f7cd8dcee10c993a6deb522cefa716d0edae9fb5423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adolescent</topic><topic>Alberta</topic><topic>Antibodies, Viral - analysis</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cost-Benefit Analysis</topic><topic>Epidemiologic Methods</topic><topic>Family Practice</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>immunity</topic><topic>Immunologic Techniques - economics</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>morbidity</topic><topic>mumps</topic><topic>Mumps - epidemiology</topic><topic>Mumps - immunology</topic><topic>Mumps - prevention & control</topic><topic>mumps vaccine</topic><topic>Mumps Vaccine - therapeutic use</topic><topic>mumps virus</topic><topic>Outcome and Process Assessment (Health Care)</topic><topic>outcome and process assessment (hearth care)</topic><topic>vaccines</topic><topic>Viral diseases</topic><topic>Viral diseases of the respiratory system and ent viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FALK, W.A.</creatorcontrib><creatorcontrib>BUCHAN, K.</creatorcontrib><creatorcontrib>DOW, M.</creatorcontrib><creatorcontrib>GARSON, J.Z.</creatorcontrib><creatorcontrib>HILL, E.</creatorcontrib><creatorcontrib>NOSAL, M.</creatorcontrib><creatorcontrib>TARRANT, M.</creatorcontrib><creatorcontrib>WESTBURY, R C.</creatorcontrib><creatorcontrib>WHITE, F.M.M.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 24</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FALK, W.A.</au><au>BUCHAN, K.</au><au>DOW, M.</au><au>GARSON, J.Z.</au><au>HILL, E.</au><au>NOSAL, M.</au><au>TARRANT, M.</au><au>WESTBURY, R C.</au><au>WHITE, F.M.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE EPIDEMIOLOGY OF MUMPS IN SOUTHERN ALBERTA, 1980-1982</atitle><jtitle>American journal of epidemiology</jtitle><addtitle>Am J Epidemiol</addtitle><date>1989-10-01</date><risdate>1989</risdate><volume>130</volume><issue>4</issue><spage>736</spage><epage>749</epage><pages>736-749</pages><issn>0002-9262</issn><eissn>1476-6256</eissn><coden>AJEPAS</coden><abstract>The full spectrum of mumps in Southern Alberta was studied over the years 1980–1982.In the community, a random sample of 3,497 children was tested for prevalence of immunity to mumps. The 1,816 who were not Immune were retested after one year. The incidence of new immunity was 16.5%. Most seroconverters had no illness suggestive of mumps. History of previous mumps or immunization were found to be unreliable predictors of serotogic immune status. In the family study, information was obtained on 342 cases diagnosed as mumps by family physician recorders.The overall complication rate was 10.8% and the secondary attack rate within families was 11.7% Hospital records of all 25 patients admitted in Calgary with mumps during the same period were analyzed. Estimated costs of unopposed mumps over 20 years compared with the estimated costs of vaccination showed that a vaccination program could give a benefit-cost ratio between 6.4 and 247 These studies show that mumps is a mild disease with relatively few serious complications or sequelae Even so, there would be definite medical and economic benefit with immunization. A low-cost addition of mumps vaccine to the immunization program would be justified.</abstract><cop>Cary, NC</cop><pub>Oxford University Press</pub><pmid>2505612</pmid><doi>10.1093/oxfordjournals.aje.a115395</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9262 |
| ispartof | American journal of epidemiology, 1989-10, Vol.130 (4), p.736-749 |
| issn | 0002-9262 1476-6256 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79201394 |
| source | MEDLINE; Periodicals Index Online; Oxford Journals Archive |
| subjects | Adolescent Alberta Antibodies, Viral - analysis Biological and medical sciences Child Child, Preschool Cost-Benefit Analysis Epidemiologic Methods Family Practice Human viral diseases Humans immunity Immunologic Techniques - economics Infant Infectious diseases Medical sciences morbidity mumps Mumps - epidemiology Mumps - immunology Mumps - prevention & control mumps vaccine Mumps Vaccine - therapeutic use mumps virus Outcome and Process Assessment (Health Care) outcome and process assessment (hearth care) vaccines Viral diseases Viral diseases of the respiratory system and ent viral diseases |
| title | THE EPIDEMIOLOGY OF MUMPS IN SOUTHERN ALBERTA, 1980-1982 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20EPIDEMIOLOGY%20OF%20MUMPS%20IN%20SOUTHERN%20ALBERTA,%201980-1982&rft.jtitle=American%20journal%20of%20epidemiology&rft.au=FALK,%20W.A.&rft.date=1989-10-01&rft.volume=130&rft.issue=4&rft.spage=736&rft.epage=749&rft.pages=736-749&rft.issn=0002-9262&rft.eissn=1476-6256&rft.coden=AJEPAS&rft_id=info:doi/10.1093/oxfordjournals.aje.a115395&rft_dat=%3Cproquest_cross%3E15460087%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1306654428&rft_id=info:pmid/2505612&rfr_iscdi=true |